February 17 - 22, 2019


Hilton Waikoloa Village
The Big Island, Hawaii

CME/CE Credit



At the conclusion of this live conference, participants should be better able to:

  • Apply the most current treatments for common and uncommon skin diseases.
  • Analyze evidence-based pharmacologic and nonpharmacologic strategies to the management of patients with acne.
  • Describe recent scientific findings that explicate the inflammatory basis of psoriasis.
  • Integrate current clinical guidelines for optimal diagnosis and treatment of psoriasis.
  • Review and cite safety and efficacy data on new and emerging therapies for psoriasis.
  • Implement a strategy for step-wise management of psoriasis with topical and biologic agents, including the use of treat-to-target goals.
  • Define appropriate goals and strategies for the optimal management of patients with rosacea.
  • Develop a treatment approach for atopic dermatitis that achieves the goal of clear or almost clear skin.
  • Compare and contrast the symptomatology of atopic dermatitis and the differences in the approach to treatment for adults and pediatric patients.
  • Assess safety and efficacy data on therapies that target the inflammatory component of atopic dermatitis.
  • Recognize the benefits and risks of current agents, devices and techniques commonly used in aesthetic and procedural dermatology.
  • Select filler agents suitable for use in treating different facial areas.
  • Design a nonsurgical treatment strategy, including use of fillers and toxins to address patient concerns about facial aging.
  • Prepare a strategic plan to address emergencies in the dermatology office, including bleeding.
  • Describe optimal approaches to diagnosing, assessing, and managing contact dermatitis.
  • Apply evidence-based treatment strategies to achieve optimal outcomes in the management of onychomycosis and other nail diseases.
  • Implement strategies for assessing and treating dermatologic conditions in pediatric patients, including acne, infections, birthmarks, hair disorders, and tumors.
  • Interpret data supporting use of current techniques in surgical dermatology.
  • Select appropriate techniques for screening patients at risk for skin cancer.
  • Choose available treatment strategies for melanoma at various stages of its progression.
  • Differentiate between benign nevi and suspicious neoplasms.
  • Assess the current and emerging treatments for BCC and SCC.




This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the University of Louisville and Skin Disease Education Foundation/ Global Academy for Medical Education, LLC. The University of Louisville is accredited by the ACCME to provide continuing education for physicians.

The University of Louisville School of Medicine designates this live activity for a maximum of 34.5 AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


The self-assessment program offered at the 43rd Hawaii Dermatology Seminar is approved by the American Board of Dermatology (ABD) for MOC-D self-assessment points.

This Live activity, Skin Disease Education Foundation's 43rd Hawaii Dermatology Seminar, with a beginning date of 02/17/2019, has been reviewed and is acceptable for up to  34.50 Prescribed credit(s) by the American Academy of Family Physicians. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and Global Academy for Medical Education. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.


Postgraduate Institute for Medicine designates this continuing education activity for 34.5 contact hours (3.45 CEUs) of the Accreditation Council for Pharmacy Education. Type of Activity Application Pharmacists have up to 30 days to complete the evaluation and claim credit for participation so that information can be submitted to CPE Monitor as required. Universal Activity Number(s)- to be listed on the handout.

The maximum number of hours awarded for this Continuing Nursing Education activity is 34.5 contact hours. Pharmacotherapy contact hours for Advanced Practice Registered Nurses will be designated on your certificate.


As a provider accredited by the ACCME, it is the policy of the University of Louisville Office of Continuing Medical Education & Professional Development to require the disclosure of anyone who is in a position to control the content of an educational activity. All relevant financial relationships with any commercial interests and/or manufacturers will be disclosed to participants at the beginning of the activity.


We encourage participation by all individuals. If you have a disability, advance notification of any special needs will help us better serve you. Please contact Global Academy for Medical Education at least 3 weeks in advance at 312.965.8006 or [email protected]

Follow Us

Jointly Provided By